The Lifesciences Magazine

  Vertical integration, digital enablement, and the creation and scalability of healthcare ecosystems are corporations’ largest and most audacious investments as the healthcare sector evolves at a rapid rate. 2022 was a slow year for Lifesciences Dealmakers in the global life sciences industry. Even as we continue to manage the COVID-19 epidemic, the benefits of merger and acquisition (M&A) are expanding inside the sector. In light of what has been learned since March 2020, companies are revising their long-term goals and gaining better clarity on the strategies, assets, and competencies required for future success. Here is How the benefits of merger and acquisition Have Helped the Market? In the first half of 2022, investors faced significant macroeconomic headwinds on a worldwide scale. Inflation, supply chain disruptions, and violent conflict substantially stopped dealmaking activity, ushering in a new era for health sciences  mergers and acquisitions . The average amou...

  Because technology is so important in every field around the world, new technological devices are invented to assist people and make their jobs easier. The healthcare and medical fields have especially benefitted from these advancements, what with the numerous technological devices and equipment developed for human healthcare.  In addition to this, the amalgamation of machine learning, automation, and artificial intelligence has made healthcare much more accessible and intelligent.  The Lifesciences Magazine is a global healthcare solutions platform that paves the way for various healthcare innovations, expert advice, and acumen, and the success stories of professionals in the field who are driving transformation with their innovative thinking.  We are proud to be one of the timeliest and thoroughly researched healthcare and life sciences journals, bringing to you the sector’s key highlights and the stories of many global health entrepreneurs who are taking a step...